# Stevens–Johnson Syndrome (SJS)

## Pathophysiology

- **Hypersensitivity reaction (Type IV, cytotoxic T-cell mediated):**

  - Drug/metabolite or infection → acts as antigen → activates CD8⁺ T-cells and NK cells
  - Release of perforin, granzyme, Fas–FasL pathway activation → widespread **keratinocyte apoptosis**
  - → Epidermal detachment, necrosis, mucosal erosions

## Causes

1. **Drugs (most common, 1–3 weeks after exposure):**

   - `Sulfonamides`
   - `Anticonvulsants` (`phenytoin`, `carbamazepine`, `lamotrigine`)
   - `Allopurinol`
   - `NSAIDs` (oxicam group, e.g., `piroxicam`)
   - `Nevirapine` (HIV therapy)

2. **Infections (esp. children):**

   - Mycoplasma pneumoniae
   - Herpes simplex virus (HSV)

3. **Others:** malignancy, idiopathic

## Clinical Features

- **Prodrome (1–3 days):**

  - Fever, malaise, sore throat, conjunctivitis
  - Arthralgia, myalgia

- **Skin lesions:**

  - Erythematous macules → targetoid lesions (atypical targets)
  - Progress → vesicles, bullae → epidermal detachment
  - Positive **Nikolsky’s sign** (skin peels on pressure)

- **Mucosal involvement (≥2 sites):**

  - Oral: painful erosions, stomatitis
  - Ocular: conjunctivitis, corneal ulceration → blindness
  - Genital: erosions, urethritis, vaginitis

- **Systemic involvement:**

  - Respiratory epithelium (pneumonitis)
  - GI (diarrhea, hepatitis)
  - Renal (acute kidney injury)

## Classification (by % Body Surface Area (BSA) detachment)

- **SJS:** \<10% BSA
- **Overlap SJS/TEN:** 10–30% BSA
- **TEN:** >30% BSA

## Complications

- Acute: sepsis, multiorgan failure, electrolyte imbalance
- Chronic: ocular sequelae (symblepharon, blindness), strictures (esophageal, urethral, vaginal), nail loss, scarring

## Investigations

### For Diagnosis

- **Clinical**: history of drug exposure + characteristic lesions
- **Skin biopsy**: full-thickness epidermal necrosis, subepidermal bullae

### For Causes

- Drug history (last 1–3 weeks)
- Serology (Mycoplasma, HSV if suspected)

### For Complications

- CBC, renal function, liver function
- Electrolytes (Na⁺, K⁺, Ca²⁺, bicarbonate)
- Sepsis screen (blood culture, urine culture)

## Management

### Emergency (ABCDEF)

- **A/B:** Oxygen, airway protection (intubation if extensive mucosal/airway involvement)
- **C:** IV fluids (similar to burns resuscitation – Parkland formula modified)
- **D:** Stop offending drug immediately
- **E:** Electrolyte correction
- **F:** Foley catheter for monitoring urine output

### Supportive

- Admit to **ICU / burns unit**
- Non-adherent dressings, sterile environment
- Analgesia
- Nutritional support (NG tube if severe oral lesions)
- Ophthalmology, urology, gynecology consults for mucosal care

### Specific

- `IV immunoglobulin (IVIG):` inhibits Fas–FasL pathway (used in TEN/SJS overlap)
- `Cyclosporine:` immunosuppressive (promising results)
- `Systemic corticosteroids:` controversial; may help early, but ↑ risk of sepsis
- `Antibiotics:` only if secondary infection documented (not prophylactic)

## Prognosis

- Mortality:

  - SJS: \~10%
  - TEN: 30–50%

- **SCORTEN score** used to predict mortality (age, HR, malignancy, %BSA, urea, bicarbonate, glucose)
